Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-22-024711
Filing Date
2022-10-25
Accepted
2022-10-25 16:57:00
Documents
1
Period of Report
2022-10-21

Document Format Files

Seq Description Document Type Size
1 RN 10252022 rdgdoc.html 4  
1 RN 10252022 rdgdoc.xml 4 7237
  Complete submission text file 0001437749-22-024711.txt   8566
Mailing Address C/O KITE PHARMA, INC. 2225 COLORADO AVENUE SANTA MONICA CA 90404
Business Address
Nussbaum Ran (Reporting) CIK: 0001609805 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38079 | Film No.: 221330088

Mailing Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007
Business Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007 972 9 770 7601
UroGen Pharma Ltd. (Issuer) CIK: 0001668243 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations